Explore how induced pluripotent stem cells and brain organoids are transforming research into Alzheimer's, Parkinson's, and other neurodegenerative diseases.
Explore the breakthrough discovery of S1P5 receptor structure and its potential for developing targeted therapies for neurodegenerative and immune disorders.
Explore how Coya Therapeutics is pioneering Treg therapies for neurodegenerative diseases like ALS and FTD through innovative immune system approaches.
Exploring the pivotal role of neuroglia in neurodegenerative diseases like Alzheimer's and Parkinson's, and the latest research breakthroughs in glia-targeted therapies.